2020.10.27_Letter to Office of Attorney General enclosing New Drug Price Reporting Dibenzyline
ABECMA_3 day Notice to Vermont_Bristol Myers Squibb
Alexion Pharmaceuticals_ Notice Pursuant to 18 V.S.A.§ 4637
Janssen Announces U.S. FDA Approval of PONVORY™
Lupin_Vermont State High Price Disclosure_3.31.2021_Signed
Meitheal Pharmaceuticals New Drug Notice – Generic Clofarabine Injection – Vermont
New Drug Report Tolvaptan_Dimethyl Fumarate_Signed 03182021
New Drug Report_MULTIPLE_03_23_2021
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(b) – ERTAPENEM
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(b) – TRAZIMERA™
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(c) – PROPOFOL EDTA
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(c) – TRAZIMERA™
Re_ Edenbridge – New Drug Notice
RE_ Jazz Pharmaceuticals, Inc. New Drug Reporting – 30 day Notice
Synagis Price Increase 03 23 21
Viela Bio, Inc.- UPLIZNA New Drug Report
VT – New Drug Introduction Notification – BioCryst
VT New Drug Reporting – Bronchitol
VT Notice of Introduction of New High-Cost Prescription Drugs – Kesimpta
VT-New Drug Introduction Notification – BioCryst